	Nephrogenic systemic fibrosis
Chronic kidney disease
Gadolinium
Children
	gadolinium-based contrast agents
age
NSF
years
patients
dose
renal dysfunction
children
risk factors
proinflammatory conditions
body
practice
previous gadolinium exposure
contrast agent
end-stage renal failure
gadodiamide exposure
gadodiamide
gadolinium
group
reports
days
kidney failure
CKD
disease
factor
condition
development
time
renal transplants
renal impairment
contrast-enhanced MR examinations
contrast-enhanced MRI

